Daniel Podzamczer

机构：Bellvitge University Hospital · ORCID：0000-0001-7090-3561

发表论文 231 篇 · 总被引 8624 次 · h-index 43

代表论文

• Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study (2021 · The Lancet HIV · 被引 110)
• Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study (2021 · Open Forum Infectious Diseases · 被引 64)
• Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected Patients (2021 · Journal of Clinical Medicine · 被引 35)
• Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial (2021 · The Lancet HIV · 被引 32)
• Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy (2021 · Biochemical Pharmacology · 被引 15)
• Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004–2018 (2022 · BMC Infectious Diseases · 被引 13)